|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/13/20 China Health Inds Holdings, Inc. 10-K 6/30/20 68:3.6M EdgarAgents LLC/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 423K
2: EX-23.1 Consent of the Independent Publicly Registered HTML 19K
Accountants
3: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 21K
12: R1 Document And Entity Information HTML 57K
13: R2 Consolidated Balance Sheets HTML 106K
14: R3 Consolidated Balance Sheets (Parentheticals) HTML 27K
15: R4 Consolidated Statements of Operations and HTML 87K
Comprehensive Income
16: R5 Consolidated Statements of Stockholders' Equity HTML 39K
17: R6 Consolidated Statements of Cash Flows HTML 103K
18: R7 Organization and Business Background HTML 32K
19: R8 Significant Accounting Policies HTML 60K
20: R9 Assets sale HTML 26K
21: R10 Accounts Receivable HTML 20K
22: R11 Inventories HTML 24K
23: R12 Construction in Progress HTML 23K
24: R13 Property, Plants and Equipment HTML 25K
25: R14 Intangible Assets HTML 25K
26: R15 Related party debts HTML 24K
27: R16 Income Taxes HTML 41K
28: R17 Earnings Per Share HTML 27K
29: R18 Commitments and Contingencies HTML 24K
30: R19 Major Suppliers and Customers HTML 22K
31: R20 Segment Reporting HTML 40K
32: R21 Subsequent Events HTML 21K
33: R22 Accounting Policies, by Policy (Policies) HTML 122K
34: R23 Significant Accounting Policies (Tables) HTML 21K
35: R24 Inventories (Tables) HTML 24K
36: R25 Construction in Progress (Tables) HTML 22K
37: R26 Property, Plants and Equipment (Tables) HTML 24K
38: R27 Intangible Assets (Tables) HTML 24K
39: R28 Related party debts (Tables) HTML 23K
40: R29 Income Taxes (Tables) HTML 41K
41: R30 Earnings Per Share (Tables) HTML 25K
42: R31 Segment Reporting (Tables) HTML 36K
43: R32 Organization and Business Background (Details) HTML 81K
44: R33 Significant Accounting Policies (Details) HTML 53K
45: R34 Significant Accounting Policies (Details) - HTML 36K
Schedule of straight-line basis over the estimated
useful life of assets
46: R35 Assets sale (Details) HTML 36K
47: R36 Accounts Receivable (Details) HTML 24K
48: R37 Inventories (Details) HTML 20K
49: R38 Inventories (Details) - Schedule of inventory HTML 29K
50: R39 Construction in Progress (Details) HTML 26K
51: R40 Construction in Progress (Details) - Schedule of HTML 25K
construction in progress
52: R41 Property, Plants and Equipment (Details) HTML 24K
53: R42 Property, Plants and Equipment (Details) - HTML 38K
Schedule of property, plants and equipment
54: R43 Intangible Assets (Details) HTML 27K
55: R44 Intangible Assets (Details) - Schedule of HTML 35K
intangible assets
56: R45 Related party debts (Details) - Schedule of HTML 26K
related party debts
57: R46 Income Taxes (Details) HTML 36K
58: R47 Income Taxes (Details) - Schedule of taxes payable HTML 30K
59: R48 Income Taxes (Details) - Schedule of HTML 39K
reconciliation between actual provision for income
taxes and the provision at the statutory rate
60: R49 Income Taxes (Details) - Schedule of provision for HTML 40K
income taxes
61: R50 Income Taxes (Details) - Schedule of components of HTML 27K
deferred tax assets
62: R51 Earnings Per Share (Details) - Schedule of basic HTML 34K
and diluted net income per share
63: R52 Major Suppliers and Customers (Details) HTML 48K
64: R53 Segment Reporting (Details) HTML 20K
65: R54 Segment Reporting (Details) - Schedule of HTML 74K
information by segment
67: XML IDEA XML File -- Filing Summary XML 121K
66: EXCEL IDEA Workbook of Financial Reports XLSX 86K
6: EX-101.INS XBRL Instance -- chhe-20200630 XML 696K
8: EX-101.CAL XBRL Calculations -- chhe-20200630_cal XML 118K
9: EX-101.DEF XBRL Definitions -- chhe-20200630_def XML 516K
10: EX-101.LAB XBRL Labels -- chhe-20200630_lab XML 971K
11: EX-101.PRE XBRL Presentations -- chhe-20200630_pre XML 514K
7: EX-101.SCH XBRL Schema -- chhe-20200630 XSD 160K
68: ZIP XBRL Zipped Folder -- 0001213900-20-031015-xbrl Zip 170K
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Xin Sun, certify that:
1. I have reviewed this Form 10-K of China Health Industries Holdings, Inc.;
2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
| a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; | |
| b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
| c) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
| d) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; |
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):
| a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
| b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting. |
| Date: October 13, 2020 | /s/ Xin Sun |
| Xin Sun | |
| Chief
Executive Officer (principal executive officer) |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/13/20 | |||
| For Period end: | 6/30/20 | NT 10-K | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/28/18 China Health Inds Holdings, Inc. 10-K 6/30/18 71:3.8M EdgarAgents LLC/FA 4/02/15 China Health Inds Holdings, Inc. 8-K:5,9 4/02/15 3:104K Newsfile Corp./FA 2/13/15 China Health Inds Holdings, Inc. 10-Q 12/31/14 65:5.2M Newsfile Corp./FA 12/31/14 China Health Inds Holdings, Inc. 8-K:1,9 12/31/14 2:32K Newsfile Corp./FA 9/29/14 China Health Inds Holdings, Inc. 10-K 6/30/14 70:5.4M Toppan Merrill/FA 10/15/13 China Health Inds Holdings, Inc. 10-K 6/30/13 77:8.3M Toppan Merrill/FA 11/16/10 China Health Inds Holdings, Inc. 10-K/A 6/30/09 21:2.7M Toppan Merrill/FA 12/01/04 China Health Inds Holdings, Inc. 10SB12G 3:112K EdgarAgents LLC/FA |